DrugPatentWatch Database Preview
TRELSTAR Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Trelstar, and when can generic versions of Trelstar launch?
Trelstar is a drug marketed by Allergan and is included in three NDAs. There is one patent protecting this drug.
This drug has forty-six patent family members in thirty-one countries.
The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
US ANDA Litigation and Generic Entry Outlook for Trelstar
Trelstar was eligible for patent challenges on June 15, 2004.
Indicators of Generic Entry
Summary for TRELSTAR
| International Patents: | 46 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 9 |
| Patent Applications: | 6 |
| Drug Prices: | Drug price information for TRELSTAR |
| DailyMed Link: | TRELSTAR at DailyMed |
Recent Clinical Trials for TRELSTAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bristol-Myers Squibb | Phase 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Sir Mortimer B. Davis - Jewish General Hospital | Phase 2/Phase 3 |
US Patents and Regulatory Information for TRELSTAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 022437-001 | Mar 10, 2010 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRELSTAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 022437-001 | Mar 10, 2010 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | Start Trial | Start Trial |
| Allergan | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRELSTAR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Sweden | 504279 | Start Trial |
| France | 2620621 | Start Trial |
| Luxembourg | 87772 | Start Trial |
| Netherlands | 194858 | Start Trial |
| Spain | 2009346 | Start Trial |
| Sweden | 9103348 | Start Trial |
| Italy | 1243357 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
